Wealthfront Advisers
NVO

Wealthfront Advisers’s Novo Nordisk NVO Stock Holding History

Wealthfront Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Buy
14,049
+244
+2% +$10.5K ﹤0.01% 807
2026
Q1 		$507K Buy
13,805
+5,348
+63% +$253K ﹤0.01% 831
2025
Q4 		$430K Buy
+8,457
New +$432K ﹤0.01% 851

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Wealthfront Advisers's NVO Position: Q2 2026 in Review

Wealthfront Advisers increased its Novo Nordisk (NVO) stake by 1.8% in Q2 2026, buying an estimated $10.5K and bringing the position to 14,049 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Wealthfront Advisers first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Wealthfront Advisers held 14,049 shares of Novo Nordisk worth $674K as of Q2 2026.
  • Wealthfront Advisers bought 244 Novo Nordisk shares in Q2 2026, an estimated $10.5K.
  • Novo Nordisk made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #807 holding.
  • Wealthfront Advisers first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.